Our News
The latest news and views from 4D Medicine Ltd, an agile biomaterials and medical device innovator.
Nottingham, 23 July 2026 – 4D Medicine Ltd, a Series A-stage medical device and biomaterials company primarily focused on advancing innovative solutions
4D Medicine Submits Q-Sub for Peripheral Nerve Protector 4D Medicine has submitted a Q-Submission (Q-Sub) to the U.S. Food and Drug Administration
4D Medicine has successfully completed cadaveric simulation testing of its Peripheral Nerve Protector in collaboration with leading peripheral nerve surgeons. The study
4D Medicine is pleased to announce that Matthew has joined the company, bringing a PhD in polymer chemistry. His expertise will support
4D Medicine is pleased to announce that Sophie Atkins has joined the company to support the development of its commercial strategy and
Second patent granted in the US for 4D Medicine Ltd. We are pleased to share the news of our second patent being
We are proud to announce that our wholly-owned subsidiary, 4D Biomaterials Ltd, is now certified to ISO 13485 – the globally recognised
4D Medicine Reports Minimal Bioburden in Pre-Sterilisation Testing 4D Medicine has confirmed that material pre-sterilisation bioburden testing has demonstrated minimal colony forming
4D Medicine Achieves ISO 13485 Certification 4D Medicine has successfully achieved ISO 13485 certification, the international standard for quality management systems in